FDA Inspection 1122513 — Kofinas Fertility Group
The FDA completed an inspection of Kofinas Fertility Group on Feb 13, 2020 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 13, 2020
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- New York, NY (United States)